Autolus(AUTL) - 2025 Q4 - Earnings Call Transcript

Autolus Therapeutics (NasdaqGS:AUTL) Q4 2025 Earnings call March 27, 2026 08:30 AM ET Company ParticipantsAmanda Cray - Executive Director of Investor RelationsChristian Itin - CEOEmily Bodnar - VP of Equity ResearchJames Shin - Director of Biopharma Equity ResearchMatt Phipps - Partner and Group Head of Biotechnology Equity ResearchRob Dolski - CFOSalim Syed - Managing DirectorConference Call ParticipantsGil Blum - Senior AnalystYanan Zhu - Senior Biotech AnalystNone - AnalystOperatorGood day and thank you ...